INHALERX LIMITED

0.040

+0.0025.26%

Volume:250.14K

Turnover:10.03K

Market Cap:8.54M

PE:-6.69

High:0.041

Open:0.040

Low:0.040

Close:0.038

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

InhaleRx procures $38.5m in funding from Clendon Biotech to progress inhaled therapies

Small Caps

·

18 Oct 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/IRX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IRX.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRX.AU\",,,,,undefined,":{"symbol":"IRX.AU","market":"AU","secType":"STK","nameCN":"INHALERX LIMITED","latestPrice":0.04,"timestamp":1741576094769,"preClose":0.038,"halted":0,"volume":250140,"delay":0,"changeRate":0.052632,"change":0.002,"floatShares":84741762,"shares":213448224,"eps":-0.005979,"lyrEps":-0.005978,"pbRate":-65.33,"amount":10031,"amplitude":0.026316,"volumeRatio":2.524393,"dividePrice":0,"prevYearClose":0.035,"fiveDayClose":0.023,"twentyDayClose":0.022},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRX.AU\",,,,,undefined,":{"symbol":"IRX.AU","floatShares":84741762,"roa":"-75.70%","roe":"-477.23%","lyrEps":-0.005978,"volumeRatio":2.524393,"shares":213448224,"dividePrice":0,"high":0.041,"amplitude":0.026316,"preClose":0.038,"low":0.04,"week52Low":0.02,"pbRate":"-65.33","psRate":"25.48","week52High":0.05,"institutionHeld":0,"latestPrice":0.04,"committee":-0.106735,"eps":-0.005979,"divideRate":0,"volume":250140,"delay":0,"ttmEps":-0.005979,"open":0.04,"prevYearClose":0.035,"prevWeekClose":0.038,"prevMonthClose":0.023,"prevQuarterClose":0.035,"fiveDayClose":0.023,"twentyDayClose":0.022,"sixtyDayClose":0.031},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IRX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IRX.AU\",market:\"AU\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IRX.AU\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IRX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2483035962","title":"Inhalerx Ltd-Ethics Approval for Phase 2 Clinical Trial of Irx-211","url":"https://stock-news.laohu8.com/highlight/detail?id=2483035962","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483035962?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:33","pubTimestamp":1731623616,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUE7HQC35:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","BK7007","IRX.AU"],"gpt_icon":0},{"id":"2476344732","title":"ASX Weekly Review: RBA Was Right on Rates and It Cost Us a Record","url":"https://stock-news.laohu8.com/highlight/detail?id=2476344732","media":"Small Caps","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476344732?lang=en_us&edition=fundamental","pubTime":"2024-10-19 08:00","pubTimestamp":1729296030,"startTime":"0","endTime":"0","summary":"There will be no letup in the political attacks against it but the share market has finally conceded that the Reserve Bank was absolutely right not to cut interest rates this year.With Australian employment growth now hitting a 16-month high and workforce participation at a record, with inflation still sticky, the Reserve Bank’s caution in holding back against the clamour of voices calling for interest rate cuts this year was well and truly justified.The share market reacted in two distinct ways.Investors now only put the chances of an interest rate cut this year from the current cash rate of 4.35% at 30% and the ASX 200 fell 72.7 points or 0.9% to 8283.2 points despite US markets firming up slightly to a fresh record.The benchmark ASX 200 fell 0.9%, or 72.7 points, to 8283.2 points, falling back from a record closing peak of 8355.9 points in the previous session.There was plenty of interesting corporate news to go around with shares in Flight Centre Travel Group  down an alarming 20.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/weekly-wrap-rba-was-right-on-rates-cost-us-record/","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["LU2098885051.SGD","RBA","BK7148","LU1303367103.USD","RIO.AU","FMG.AU","APA.AU","BK7041","BK7507","BK7076","BK7129","BK4113","BHP.AU","BK4137","BK7501","NVU.AU","RPL.AU","TTM.AU","BK7142","MKG.AU","BK7070","CBD","NEM.AU","IRX.AU","LU0757428866.USD","BK7506","BK7511","LU1815336091.USD","XJO.AU","NST.AU","XKO.AU","BK7095","FLT.AU","BK7094","GLL.AU","BK7007","GOR.AU","VEN.AU","XAO.AU","BK7062","HVN.AU","AUE.AU","BK7104","DEG.AU","RRL.AU","BK7153"],"gpt_icon":1},{"id":"2476411324","title":"BUZZ-Australia's Inhalerx doubles in value on funding deal for clinical trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2476411324","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476411324?lang=en_us&edition=fundamental","pubTime":"2024-10-18 11:02","pubTimestamp":1729220574,"startTime":"0","endTime":"0","summary":"** Shares of Inhalerx    surge as much as 127.3% to A$0.050, their biggest pct gain since March 2020   ** Medical device maker to get up to A$38.5 mln  in funds from Clendon Biotech Capital to cover clinical trial costs   ** Stock hits its highest level since late March   ** Around 3.7 mln shares change hands, 72.3x the 30-day avg   ** Stock up 34.5% YTD, including current session, as at 0140 GMT ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAO.AU","IRX.AU","XJO.AU","XKO.AU","BK7094","BK7007"],"gpt_icon":0},{"id":"2476117764","title":"InhaleRx procures $38.5m in funding from Clendon Biotech to progress inhaled therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2476117764","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476117764?lang=en_us&edition=fundamental","pubTime":"2024-10-18 11:01","pubTimestamp":1729220471,"startTime":"0","endTime":"0","summary":"Healthcare company InhaleRx  has entered into an agreement with Melbourne-headquartered Clendon Biotech Capital to provide up to $38.5 million in funding to cover costs associated with developing it’s unique inhaled therapies.Clendon’s funding will fully cover the costs – including those from associated non-clinical work and trial drug manufacturing – for the IRX-211 and IRX-616a drug development plans through to the completion of Phase 2 clinical trials.The funding will also enable InhaleRx to address the requirements of the US Food and Drug Administration  relevant to its recent investigational new drug  application for IRX-616a.IRX-211 is being evaluated for the treatment of breakthrough cancer pain in opioid-tolerant patients, while IRX-616a is an innovative drug-device medication designed to offer fast and effective relief for individuals suffering from the debilitating panic disorder  condition.“While this partnership provides vital support for our clinical development program, w","market":"hk","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2024/10/InhaleRX-ASX-IRX-Clendon-Biotech-Capital-funding.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2024/10/InhaleRX-ASX-IRX-Clendon-Biotech-Capital-funding.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/inhalerx-procures-funding-clendon-biotech-progress-inhaled-therapies/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["LU1169589451.USD","BK7095","CBD","PD","IRX.AU","IND.AU","BK4113","LU1169590202.USD","BK7094","BK7007","BK4023"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8}]}}